Anti-obesity medication use in adolescents: risks and benefits.
Publication
, Journal Article
Freemark, M; Kiess, W
Published in: Pediatr Endocrinol Rev
November 2004
Pharmacological agents currently used to treat obese adolescents decrease appetite or reduce fat absorption from the gastrointestinal tract. This paper summarizes the indications for pharmacotherapy and the potential benefits and risks of anti-obesity medications.
Duke Scholars
Published In
Pediatr Endocrinol Rev
ISSN
1565-4753
Publication Date
November 2004
Volume
2 Suppl 1
Start / End Page
168 / 170
Location
Israel
Related Subject Headings
- Risk Assessment
- Obesity
- Humans
- Endocrinology & Metabolism
- Anti-Obesity Agents
- Adolescent
- 3215 Reproductive medicine
- 3213 Paediatrics
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
Citation
APA
Chicago
ICMJE
MLA
NLM
Freemark, M., & Kiess, W. (2004). Anti-obesity medication use in adolescents: risks and benefits. Pediatr Endocrinol Rev, 2 Suppl 1, 168–170.
Freemark, Michael, and Wieland Kiess. “Anti-obesity medication use in adolescents: risks and benefits.” Pediatr Endocrinol Rev 2 Suppl 1 (November 2004): 168–70.
Freemark M, Kiess W. Anti-obesity medication use in adolescents: risks and benefits. Pediatr Endocrinol Rev. 2004 Nov;2 Suppl 1:168–70.
Freemark, Michael, and Wieland Kiess. “Anti-obesity medication use in adolescents: risks and benefits.” Pediatr Endocrinol Rev, vol. 2 Suppl 1, Nov. 2004, pp. 168–70.
Freemark M, Kiess W. Anti-obesity medication use in adolescents: risks and benefits. Pediatr Endocrinol Rev. 2004 Nov;2 Suppl 1:168–170.
Published In
Pediatr Endocrinol Rev
ISSN
1565-4753
Publication Date
November 2004
Volume
2 Suppl 1
Start / End Page
168 / 170
Location
Israel
Related Subject Headings
- Risk Assessment
- Obesity
- Humans
- Endocrinology & Metabolism
- Anti-Obesity Agents
- Adolescent
- 3215 Reproductive medicine
- 3213 Paediatrics
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine